This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0452U only for EarlyTect® Bladder Cancer Detection (EarlyTect® BCD), Promis Diagnostics Inc. The test, on a urine specimen, uses linear target enrichment–quantitative methylation–specific real–time PCR (LTE–qMSP) for methylated PENK DNA detection. PENK methylation is a biomarker of bladder cancer, and the results are reported as the likelihood of bladder cancer.
For clinical responsibility, terminology, tips and additional info
start codify free trial.